Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.
Sponsor: Faeth Therapeutics
Check if you qualify for this endometrial cancer clinical trial in New York, NY
If you're searching for endometrial cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.